Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2023

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • Connected Intelligence
  • AI & Machine Learning
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Genomics
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
AI & Machine Learning with a healthcare IQ.

Artificial intelligence is accelerating opportunities. Realizing the benefits for healthcare requires the right expertise. Together, we can solve the problems of today, and drive the breakthroughs of tomorrow.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
Unlock the power of genomic research.

IQVIA enables genomic research via global access to a network of genomic-clinical data, proprietary technologies that enable federated analytics, and therapeutic area & bioinformatics expertise to help you answer your most pressing research questions.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Blog
Embrace hybrid HCP engagement or risk falling behind
Recent IQVIA research has shown that the hybrid model for HCP engagement is here to stay.
Liz Murray, Global Lead, Centre for Excellence in HCP Engagement Contract Sales & Medical Solutions
Feb 25, 2022
  • Blogs
  • Embrace hybrid HCP engagement or risk falling behind

Over the last couple of years, interactions between healthcare professionals (HCPs) and life sciences companies have changed immensely. The COVID-19 pandemic forced companies to change their ways of working, as in-person interactions were significantly restricted, and the use of digital approaches heightened to replace the usual ways of engaging.

As the industry adapts to the world that has been significantly impacted by the pandemic, the hybrid approach — where former field-based colleagues are doing both face-to-face and virtual or remote interactions — is fast becoming the optimal model for successful HCP engagement.

The hybrid model is here to stay

Recent IQVIA research1 has shown that the hybrid model for HCP engagement is here to stay. HCPs still want and value in-person interactions, as they believe face-to-face meetings are essential for building and maintaining trust with representatives. However, HCPs also positively value remote engagement, due to the time efficiency, flexibility, and increased collaboration that it can provide. It has become clear that both in-person and remote communication channels demonstrate benefits and drawbacks for engagement between HCPs and life sciences companies.

Therefore, to successfully engage with HCPs moving forward, life sciences companies will need to adapt their engagement strategies to ultimately provide the “best of both worlds”. Engagement strategies will not require shifting solely to digital or in-personal interactions, but instead, companies will need to learn how to effectively combine them. A more flexible, omnichannel, customer-centric model is key.

Some companies are ahead of the curve

While the pharmaceutical industry can often move slowly, and it has taken some time to adapt to remote engagement, it’s clear that some companies are already ahead of the curve in keeping up with this evolving landscape. In a recent webinar, Brave new world: Embracing ‘hybrid’ HCP engagement, available on demand here, we asked the attendees to answer three key questions, to understand where organizations currently stand with the hybrid model, their challenges, and what the future holds.

1. Where is your organization now in adapting field roles to also embrace remote engagement in a ‘hybrid’ model?

Out of 133 respondents, two thirds have been adapting field roles to embrace remote engagement in a hybrid model for some time.


2. What are the key challenges for your organization in adapting field roles to also embrace remote engagement in a ‘hybrid’ model?

Out of 110 respondents, all respondents are still struggling with some aspects of remote engagement, and almost 40% are struggling with all of it.


3. What's next for your organization in adapting field roles to also embrace remote engagement in a ‘hybrid’ model?

Out of 101 respondents, just under a quarter are still piloting and only 13% feel they have got it right so far.


Out of 101 respondents, just under a quarter are still piloting and only 13% feel they have got it right so far. Overall, the results from the poll demonstrate that the majority of the respondents have already been adapting field roles within their organization to embrace remote engagement in the hybrid model of HCP engagement. However, all respondents identified key challenges in adapting these roles, and over half of the respondents recognize that there is room for improvement in the future.

How IQVIA can support you with your HCP engagement

Moving forward, how can life sciences companies overcome their challenges and fully embrace the hybrid approach to HCP engagement? IQVIA has identified 7 key success factors:

You can read about the 7 key success factors in more detail, here.

At IQVIA Contract Sales & Medical Solutions, we have over 20 years of experience providing smart, representative-driven HCP engagement solutions, including remote, hybrid and face-to-face teams. In the last two years (2019 and 2020), we supported more than 90 life sciences customers with HCP remote engagement solutions, covering multiple therapy areas, across 31 countries.

The hybrid model is here to stay – get in touch today to see how we can help you embrace this approach and ensure successful HCP engagement.


1IQVIA. Understand the Impact of COVID-19 on Optimal Healthcare Professional Communication. June 2021.
https://www.iqvia.com/library/publications/understand-the-impact-of-covid19-on-optimal-healthcare-professional-communication 

Contact Us